SARS-CoV-2/COVID-19, PCR test

The ARS-CoV-2/COVID-19, PCR test is a Real-Time RT-PCR test using the CDC multiple target molecular assay. This test is intended to be performed on respiratory specimens and used to aid in the detection of the COVID-19 respiratory disease.

Result Interpretation

  • Positive: Both 2019-nCov markers were detected in the sample, considered a positive test result for COVID-19.
  • Not Detected: Extraction control detected but both 2019-nCov markers were not present above the limit of detection.
  • Inconclusive: Not all markers were found in the sample, sample recollection suggested.
  • For more information see pages 33-35:

Specimen Collection

MHS Labs provides kits with a nasopharyngeal (NP) swab and a vial of molecular transport media. Collection by a trained healthcare professional is recommended. MHS’s next-generation transport media deactivates the virus at the point of collection and provides sample stability at room temperature for up to 30 days.

Essential Neutralizing Antibody Covid Test

This test measures the body’s active ability to respond to viral infection of Sars-Cov-2 (Covid-19). It is the most accurate assessment of individual and group neutralizing antibody presence and whether that count is high or low.

Learn more about ENACT

Collected with a single finger prick, this blood test helps populations and cohorts to understand overall neutralizing antibody presence and level of immunity.  Its simple at-home collection is useful to inform:

  • vaccine efficacy and allocation
  • population health preparedness
  • regulation, protocol and outreach

Organizations that benefit from quick and reliable neutralizing antibody testing include vaccine pharma, academic research, employer groups and government agencies.

Elecsys® Anti-SARS-CoV-2 Antibody Test

The Elecsys® Anti-SARS-CoV-2 Antibody Test is an immunoassay intended for the qualitative detection of antibodies to SARSCoV2 (COVID-19) in human serum and plasma (K2EDTA, K3EDTA, Liheparin).

The test is intended for use as an aid in identifying individuals with an adaptive immune response to SARSCoV2, indicating recent or prior infection.

SARS-CoV-2/COVID-19 with Influenza Profile, PCR test (P10012)

“Clinicians are encouraged to consider testing for other causes of respiratory illness such as influenza, in addition to testing for SARS-CoV-2” – CDC

Acute respiratory infection remains the leading cause of death among geriatric and immunocompromised patients. For infectious diseases that interfere with normal breathing, it is essential to detect multiple pathogens simultaneously.

  • Make clinical decisions on a wide array of infections
  • Reduce the time to treatment
  • Target and personalize therapy

With our SARS-CoV-2/COVID-19 with Influenza Profile, PCR test (P10012), MHS Labs can detect and differentiate RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper respiratory specimens at the same time.

The tests can be ordered as individual order choices and combination or reflex panels using the same specimen/swab and most accurate PCR method without compromising the rapid COVID-19 test turnaround times.